The chief executive officer of Gamida Cell discussed upcoming research on 2 of their investigational agents, GDA-201 and omidubicel, for hematological malignancies.
Julian Adams, PhD
Advertisement
Chief executive officer, Gamida Cell
Articles by Julian Adams, PhD
The chief executive officer of Gamida Cell discussed the company's novel approach to cell proliferation.
Advertisement
Latest Updated Articles
Improving Bone Marrow Transplant With OmidubicelJune 22nd 2021
Advertisement
Advertisement